Endeavor Private Wealth Inc. bought a new position in The Procter & Gamble Company (NYSE:PG – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 443 shares of the company’s stock, valued at approximately $74,000.
A number of other hedge funds have also added to or reduced their stakes in PG. Bill Few Associates Inc. boosted its position in shares of Procter & Gamble by 0.3% during the fourth quarter. Bill Few Associates Inc. now owns 32,255 shares of the company’s stock valued at $5,408,000 after buying an additional 101 shares during the last quarter. MinichMacGregor Wealth Management LLC boosted its position in shares of Procter & Gamble by 23.0% during the fourth quarter. MinichMacGregor Wealth Management LLC now owns 1,724 shares of the company’s stock valued at $289,000 after buying an additional 322 shares during the last quarter. Raleigh Capital Management Inc. boosted its position in shares of Procter & Gamble by 2.0% during the fourth quarter. Raleigh Capital Management Inc. now owns 9,414 shares of the company’s stock valued at $1,578,000 after buying an additional 187 shares during the last quarter. D.B. Root & Company LLC boosted its position in Procter & Gamble by 7.0% in the fourth quarter. D.B. Root & Company LLC now owns 3,579 shares of the company’s stock worth $600,000 after purchasing an additional 235 shares during the last quarter. Finally, Echo45 Advisors LLC boosted its position in Procter & Gamble by 25.9% in the fourth quarter. Echo45 Advisors LLC now owns 1,562 shares of the company’s stock worth $258,000 after purchasing an additional 321 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on PG shares. Stifel Nicolaus upped their price target on Procter & Gamble from $161.00 to $165.00 and gave the company a “hold” rating in a research report on Thursday. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Barclays boosted their price objective on Procter & Gamble from $155.00 to $159.00 and gave the company an “equal weight” rating in a research note on Thursday. DA Davidson reiterated a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research note on Thursday. Finally, Evercore ISI boosted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $180.53.
Insider Activity at Procter & Gamble
In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the transaction, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Stock Down 1.0 %
Shares of NYSE:PG opened at $164.41 on Friday. The Procter & Gamble Company has a 52-week low of $152.06 and a 52-week high of $180.43. The firm has a market capitalization of $387.20 billion, a P/E ratio of 26.18, a P/E/G ratio of 3.69 and a beta of 0.45. The stock has a 50 day moving average price of $168.96 and a 200-day moving average price of $169.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.55 and a current ratio of 0.76.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.88% and a net margin of 18.35%. The firm had revenue of $21.88 billion during the quarter, compared to analyst estimates of $21,657,595.49 billion. During the same quarter in the prior year, the company earned $1.84 EPS. The business’s revenue was up 2.1% compared to the same quarter last year. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date is Friday, January 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.01%.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- About the Markup Calculator
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Short Selling – The Pros and Cons
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.